CR

Chandrakant Rajaram Kale

Active Director Director DIN 08257365
DIN 08257365 First appointment Oct 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandrakant Rajaram Kale

Data last updated:

Chandrakant Rajaram Kale is a Director at Sukarta Healthcare Private Limited (since 2018). The company operates in Business Services.

DIN 08257365
Primary Designation Director
Industry Business Services
First Appointment 15 Oct 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sukarta Healthcare Private Limited U74999PN2018PTC179590
Director15 Oct 20182018Active

Board colleagues of Chandrakant Rajaram Kale

NameDINCompanyDesignation
Rohini Ramesh Malwade08257366Sukarta Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sukarta Healthcare Private Limited
Premium access

Shareholding and investment profile for Chandrakant Rajaram Kale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrakant Rajaram Kale

Chandrakant Rajaram Kale currently holds 1 directorship: Sukarta Healthcare Private Limited (Director, since 15 Oct 2018).

Chandrakant Rajaram Kale was first appointed on 15 Oct 2018 as Director at Sukarta Healthcare Private Limited.

The current boards of Chandrakant Rajaram Kale's companies include Rohini Ramesh Malwade (Sukarta Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available